Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monoamines and schizophrenia.

G Sedvall1

  • 1Department of Psychiatry and Psychology, Karolinska Institute, Stockholm, Sweden.

Acta Psychiatrica Scandinavica. Supplementum
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Central biogenic amines are implicated in schizophrenia. While cerebrospinal fluid studies show varied results, postmortem analysis consistently reveals increased dopamine D2 receptors in schizophrenic brains, though the cause remains unclear.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased frequency of aberrant CSF circulation in schizophrenic patients compared to healthy volunteers.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same author

A systematic genomewide linkage study in 353 sib pairs with schizophrenia.

American journal of human genetics·2003
Same author

Reliability and reproducibility of brain tissue volumetry from segmented MR scans.

European archives of psychiatry and clinical neuroscience·2002
Same author

Characterization of human cleaved N-CAM and association with schizophrenia.

Experimental neurology·2001
Same author

Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743.

Brain research·2001
Same author

No association between serotonin 2A receptor gene variants and personality traits.

Psychiatric genetics·2001

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • The role of central biogenic amines in schizophrenia pathophysiology is hypothesized due to drug effects on dopamine, noradrenaline, and serotonin pathways.
  • Structural similarities between hallucinogens (e.g., amphetamine, mescaline, LSD) and neurotransmitters support their impact on central transmitter systems.

Purpose of the Study:

  • To investigate the role of central biogenic amines in schizophrenia.
  • To examine dopamine D2 receptor function and its significance in schizophrenia.

Main Methods:

  • Analysis of aminergic functions in postmortem and living schizophrenic patients.
  • Measurement of biogenic amine metabolite levels in cerebrospinal fluid and plasma.
  • Examination of aminergic receptor structures in postmortem human brain.

Related Experiment Videos

  • Positron emission tomographic (PET) scanning to study D2 receptors.

    • Main Results:

    • Cerebrospinal fluid and plasma metabolite analyses yielded inconsistent results regarding amine release.
    • Postmortem brain studies consistently showed increased D2 receptor density in the basal ganglia of schizophrenic patients.
    • PET scan studies presented mixed findings on D2 receptor densities in schizophrenia.

    Conclusions:

    • The exact role of dopamine D2 receptor alterations in schizophrenia pathophysiology requires further investigation.
    • It remains to be determined whether observed D2 receptor changes are a primary feature of schizophrenia or a drug-induced effect.